Opthea Limited Cash and Cash Equivalents 2011-2026 | OPT

Annual Cash and Cash Equivalents Opthea Limited

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
44.6 M	118 M	42.7 M	15.1 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
118 M	15.1 M	55.1 M

Quarterly Cash and Cash Equivalents Opthea Limited

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	88.3 M	-	118 M	-	156 M	-	42.7 M	-	-	-	15.1 M	-	-	-	24.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
156 M	15.1 M	74.1 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	34.8 M	$ 3.83	2.56 %	$ 9.21 B	Australia
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	1.66 B	$ 327.37	-1.81 %	$ 42.9 B	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
AlloVir ALVR	98.1 M	-	4.14 %	$ 49.1 M	USA
Burford Capital Limited BUR	322 M	$ 4.74	0.21 %	$ 767 M	Britain
Cabaletta Bio CABA	83 M	$ 3.48	2.39 %	$ 350 M	USA
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	18.3 M	$ 8.22	10.78 %	$ 81.3 M	USA
Allakos ALLK	66.4 M	-	-	$ 28.6 M	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Midatech Pharma plc MTP	8.53 M	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	49.9 M	-	-	$ 8.42 M	USA
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	29 K	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	170 M	$ 21.55	-0.6 %	$ 1.01 B	USA
CymaBay Therapeutics CBAY	207 M	-	-	$ 3.45 B	USA
BioNTech SE BNTX	7.68 B	$ 100.72	1.25 %	$ 27.2 B	Germany
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	7.31 M	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 3.1	-2.21 %	$ 5.1 M	Israel
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	8.91 M	-	-5.16 %	$ 5.39 M	USA
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	185 M	$ 1.42	-8.71 %	$ 365 M	USA
Galectin Therapeutics GALT	17.7 M	$ 2.39	-6.65 %	$ 153 M	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	121 M	$ 4.18	-1.3 %	$ 447 M	USA
Arcutis Biotherapeutics ARQT	42.9 M	$ 24.21	-1.53 %	$ 3.08 B	USA
AIkido Pharma AIKI	34 M	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	112 M	-	-4.8 %	$ 255 M	USA
Grifols, S.A. GRFS	980 M	$ 8.58	-1.27 %	$ 6.83 B	Spain
Autolus Therapeutics plc AUTL	104 M	$ 1.52	1.68 %	$ 405 M	Britain
Aptose Biosciences APTO	935 K	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	4.55 B	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	6.6 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	16.2 M	-	-16.75 %	$ 25.8 M	USA
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	28.9 M	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	28.9 M	$ 33.67	-0.61 %	$ 2.24 B	USA
bluebird bio BLUE	222 M	-	-	$ 546 M	USA